VANGUARD GROUP INC 13D and 13G filings for Relay Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:13 pm Purchase | 2023-12-29 | 13G | Relay Therapeutics, Inc. RLAY | VANGUARD GROUP INC | 10,650,387 8.640% | 266,169 (+2.56%) | Filing |
| 2023-02-09 11:30 am Purchase | 2022-12-30 | 13G | Relay Therapeutics, Inc. RLAY | VANGUARD GROUP INC | 10,384,218 8.590% | 4,185,776 (+67.53%) | Filing |
| 2022-02-10 08:32 am Purchase | 2021-12-31 | 13G | Relay Therapeutics, Inc. RLAY | VANGUARD GROUP INC | 6,198,442 5.740% | 6,198,442 (New Position) | Filing |